05-01-2022 19:30 via finanzen.net

NOXXON Provides Update on Evaluation of NOX-A12 in Non-Oncology Indication by a Leading International Pharma Company

Regulatory News:NOXXON Pharma N.V.(Euronext Growth Paris:...